Mandate

Vinge advises EOS Russia

May 30, 2008

Vinge has been advising and representing EOS Russia in connection with the completion of the company’s series of share issues, directed to investors in Sweden and abroad. The offer was effectuated through “reoccurring demand driven pricing and settlement” and, following completion of the offer, the total proceeds of issue amounted to approximately SEK 2.1 billion. Participating banks in the transaction were Troika Dialog and Carnegie.

The Vinge team principally included Lena Almefelt, Rikard Stenberg, Petter Alberts, Henrik Fritz, Andreas Johard and Johan Thiman.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025